"Dead or alive?": How and why myocardial viability imaging by cardiac MRI works;"Tot oder lebendig?": Wie und warum myokardiale vitalitätsdiagnostik mit MRT funktioniert

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 179, Issue 10, 2007, Pages 1016-1024

  Hunold, Peter ^a   Kreitner, K F ^b   Barkhausen, J ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Gadolinium; Heart; MR imaging; Tissue characterization

Indexed keywords

HEART MUSCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

CONTRAST MEDIA; CORONARY ARTERY BYPASS; CORONARY DISEASE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; REFERENCE STANDARDS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 35349025305     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963199     Document Type: Review

References (49)

1. Gropler RJ, Bergmann SR. Myocardial viability - what is the definition? J Nucl Med 1991; 32: 10-12
2. Kloner RA, Przyklenk K. Hibernation and stunning of the myocardium. N Engl J Med 1991; 325: 1877-1879
3. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149
4. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221
5. Baer FM, Voth E, Schneider CA et al. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995; 91: 1006-1015
6. Sklenar J, Ismail S, Villanueva FS et al. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion. An experimental evaluation. Circulation 1994; 90: 1502-1512
7. Baer FM, Theissen P, Schneider CA et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31: 1040-1048
8. Wellnhofer E, Olariu A, Klein C et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004; 109: 2172-2174
9. Baumgartner H, Porenta G, Lau YK et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol 1998; 32: 1701-1708
10. Barkhausen J, Ruehm SG, Goyen M et al. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology 2001; 219: 264-269
11. Carr JC, Simonetti O, Bundy J et al. Cine MR angiography of the heart with segmented true fast imaging with steady-state precession. Radiology 2001; 219: 828-834
12. Cerqueira MD, Weissman NJ, Dilsizian V et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542
13. Edelman RR. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology 2004; 232: 653-668
14. Hendel RC, Patel MR, Kramer CM et al. ACCF/ACR/SCCT/SCMR/ASNC/ NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006; 48: 1475-1497
15. Rehr RB, Peshock RM, Malloy CR et al. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. Am J Cardiol 1986; 57: 864-868
16. Saeed M, Wendland MF, Watzinger N et al. MR contrast media for myocardial viability, microvascular integrity and perfusion. Eur J Radiol 2000; 34: 179-195
17. Inoue S, Murakami Y, Ochiai K et al. The contributory role of interstitial water in Gd-DTPA-enhanced MRI in myocardial infarction. J Magn Reson Imaging 1999; 9: 215-219
18. Hillenbrand HB, Kim RJ, Parker MA et al. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000; 102: 1678-1683
19. Simonetti OP, Kim RJ, Fieno DS et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218: 215-223
20. Mahnken AH, Gunther RW, Krombach G. Kontrastangehobene MRT und MSCT zur kardialen Vitalitätsdiagnostik. Fortschr Röntgenstr 2006; 178: 771-780
21. Niendorf T, Sodickson D. Beschleunigung der kardiovaskulären MRT mittels paralleler Bildgebung: Grundlagen, praktische Aspekte, klinische Anwendungen und Perspektiven. Fortschr Röntgenstr 2006; 178: 15-30
22. Kellman P, Arai AE, McVeigh ER et al. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002; 47: 372-383
23. Huber AM, Schoenberg SO, Hayes C et al. Phase-sensitive inversion-recovery MR imaging in the detection of myocardial infarction. Radiology 2005; 237: 854-860
24. Petersen SE, Mohrs OK, Horstick G et al. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging. J Cardiovasc Magn Reson 2004; 6: 541-548
25. Choi SI, Jiang CZ, Lim KH et al. Application of breath-hold T2-weighted, first-pass perfusion and gadolinium-enhanced T1-weighted MR imaging for assessment of myocardial viability in a pig model. J Magn Reson Imaging 2000; 11: 476-480
26. Rochitte CE, Lima JA, Bluemke DA et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998; 98: 1006-1014
27. Beek AM, Kuhl HP, Bondarenko O et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003; 42: 895-901
28. Lima JA, Judd RM, Bazille A et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995; 92: 1117-1125
29. Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-772
30. Sandstede JJ, Beer M, Lipke C et al. Time course of contrast enhancement patterns after Gd-BOPTA in correlation to myocardial infarction and viability: a feasibility study. J Magn Reson Imaging 2001; 14: 789-794
31. Bouchard A, Reeves RC, Cranney G et al. Assessment of myocardial infarct size by means of T2-weighted 1H nuclear magnetic resonance imaging. Am Heart J 1989; 117: 281-289
32. Stork A, Muellerleile K, Bansmann PM et al. Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate between acute and chronic myocardial infarction. Eur Radiol 2007; 17: 610-617
33. Abdel-Aty H, Zagrosek A, Schulz-Menger J et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004; 109: 2411-2416
34. Aletras AH, Tilak GS, Natanzon A et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006; 113: 1865-1870
35. Kim RJ, Fieno DS, Parrish TB et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002
36. Bulow H, Klein C, Kuehn I et al. Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease. Heart 2005; 91: 1158-1163
37. Hunold P, Schlosser T, Vogt FM et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. Am J Roentgenol 2005; 184: 1420-1426
38. Bogaert J, Dymarkowski S. Delayed contrast-enhanced MRI: use in myocardial viability assessment and other cardiac pathology. Eur Radiol 2005; 15: B52-58
39. Stork A, Mullerleile K, Bansmann PM et al. Muster der späten Kontrastmittelanreicherung in der MRT bei ischämischen und nicht-ischämischen Kardiomyopathien. Fortschr Röntgenstr 2007; 179: 21-30
40. Dendale P, Franken PR, Block P et al. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J 1998; 135: 875-880
41. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453
42. Bove CM, DiMaria JM, Voros S et al. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting - initial experience. Radiology 2006; 240: 835-841
43. Hunold P, Brandt-Mainz K, Freudenberg L et al. Myokardiale Vitalitätsdiagnostik mit kontrastverstärkter Magnetresonanztomographie - Vergleich des "late enhancement"-Konzepts mit der Positronen-Emissions-Tomographie. Fortschr Röntgenstr 2002; 174: 867-873
44. Klein C, Nekolla SG, Bengel FM et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002; 105: 162-167
45. Ramani K, Judd RM, Holly TA et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998; 98: 2687-2694
46. Gerber BL, Rochitte CE, Bluemke DA et al. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation 2001; 104: 998-1004
47. Barkhausen J, Hunold P, Eggebrecht H et al. Detection and characterization of intracardiac thrombi on MR imaging. Am J Roentgenol 2002; 179: 1539-1544
48. Ladd SC, Zenge M, Antoch G et al. MR-Ganzkörperdiagnostik. Fortschr Röntgenstr 2006; 178: 763-770
49. Fenchel M, Jost D, Kramer U et al. Kardiovaskuläre MR-Ganzkörperbildgebung bei Patienten mit symptomatischer Atherosklerose der peripheren Gefäße. Fortschr Röntgenstr 2006; 178: 491-499